Calfer

Quick links to important sections

Calfer

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Calfer

Quick Facts

Property Description
Active ingredient Calcium Carbonate
Form Tablet, Chewable tablet, Capsule
Pharmacological class Mineral Supplement, Antacid, Phosphate Binder
Common purpose Supports mineral balance and neutralizes stomach acid
Origin Inorganic, Synthetic

What is Calfer and Its Core Ingredient?

Calfer is an oral medicinal preparation primarily defined by its active ingredient, Calcium Carbonate (CaCO3), an essential inorganic salt used to support the body's mineral balance and neutralize excess stomach acid. The preparation is widely recognized for its efficacy in supplementing calcium intake and providing symptomatic relief from high gastric acidity. This compound is classified by authoritative bodies for its dual role as a Mineral Supplement and an Antacid.

Calfer's formulation may be a single active ingredient product or a combination product, frequently including Cholecalciferol (Vitamin D3). The presence of Cholecalciferol reflects a common formulation strategy designed to enhance the absorption of the elemental calcium component.


Calfer's Type and General Purpose

Pharmacologically, Calfer belongs to the class of Antacids and Adsorbents, alongside its crucial role in mineral supplementation. Its general purpose is multifaceted: to correct or prevent calcium deficiency and to provide prompt relief from the symptoms associated with excess gastric acidity, such as occasional heartburn. For instance, literature supports its use in various contexts, including its function as a phosphate binder. The available context confirms that the medicine is utilized in situations requiring the swift chemical buffering of stomach acid or the long-term support of skeletal health.


Common Forms of Calfer

Calfer is exclusively administered via the oral dosage form. The physical preparations available typically include the tablet, the chewable tablet, and the capsule. The availability of the chewable tablet is a differentiating factor, as it allows patients experiencing rapid-onset symptoms, such as acute acid indigestion, to utilize the carbonate anion for quick neutralization.

What side effects are possible with Calfer?

Possible Side Effects and Safety Information

The safety profile of Calfer (Calcium Carbonate) is detailed in official regulatory sources, which classify potential reactions by their frequency and the physiological system affected. The statements below summarize the officially documented safety constraints and adverse reactions.


Documented Adverse Reactions and Frequencies

Adverse effects are primarily observed in the gastrointestinal system and metabolism. Reactions are classified according to regulatory standards:

Classification Examples of Adverse Reactions
Uncommon Hypercalcemia (elevated blood calcium), Hypercalciuria
Rare Constipation, Flatulence, Nausea, Abdominal pain, Diarrhea

The systems involved are mainly Gastrointestinal Disorders and Metabolism and Nutrition Disorders. The regulatory profile notes that while gastrointestinal effects are the most commonly observed reactions, the most significant systemic risk is Hypercalcemia.


Serious Reactions and Safety Constraints

The most serious, though rare, safety consideration associated with prolonged use of high doses is the potential for Milk-alkali syndrome. This serious adverse reaction is a regulatory concern tied specifically to high, long-term intake, potentially leading to renal complications.

Official labeling defines specific safety constraints, stipulating that Calfer is contraindicated in patients with pre-existing conditions such as Hypercalcemia, Severe Hypercalciuria, Nephrolithiasis (kidney stones), or Severe Renal Insufficiency. Furthermore, regulatory texts specify caution for individuals with Renal impairment, who are considered at increased risk for developing Hypercalcemia.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of Calfer (Calcium Carbonate) is officially documented to result primarily in hypercalcemia (excess calcium in the blood) and metabolic alkalosis. The documented clinical manifestations are wide-ranging, often presenting with gastrointestinal effects such as nausea, vomiting, constipation, and abdominal pain. Systemic and neurological signs may include weakness, confusion, thirst, or continuous headache.


Regulatory documents classify overdose as potentially leading to severe or life-threatening outcomes affecting the renal and cardiovascular systems. Officially listed complications include nephrolithiasis (kidney stones) and renal insufficiency, as well as cardiac dysrhythmias (irregular heartbeat) or coma in extreme cases. Individuals with pre-existing kidney impairment are noted to have increased susceptibility to these severe effects. The risk is specifically associated with the ingestion of large doses over an extended period.


Mandated Emergency Actions

In the event of a suspected overdose, regulatory guidance requires the patient to seek immediate medical attention or contact a Poison Control Center immediately. Prompt medical help is critical, as management involves symptomatic and supportive treatment to correct the underlying hypercalcemia, including measures like intravenous fluids, monitoring of vital signs and heart function (ECG), and potentially gastric emptying procedures. No specific antidote is known for Calcium Carbonate overdose.

Therapeutic Uses of Calfer

What Calfer Treats: Main Uses and Benefits

Calfer, a compound containing both calcium and iron, is generally used to provide symptomatic relief and supportive therapeutic benefit in conditions associated with systemic imbalance or mineral deficiencies. These deficiencies may lead to symptoms that create noticeable physiological strain across multiple systems.

Support for Symptom Management

The therapeutic benefits of Calfer involve managing symptoms related to skeletal and mineral symptom burden, easing pronounced symptoms of deficiency (like fatigue and weakness), and providing support during acute symptomatic episodes. It is applied in contexts where additional symptomatic support is needed for joint health and functional stability, as well as in situations where symptoms interfere with daily functioning. It is relevant in contexts marked by increased discomfort or tension associated with the body's requirements for structural support. For example, iron is needed for healthy blood function.

“Calfer supports the patient during difficult episodes by easing distress and assists with functional stability during symptomatic phases when low vitality symptoms are temporarily overwhelming.”

The compound contributes to easing the overall symptom load associated with structural discomfort and supports general well-being during symptomatic phases.

Quick Fact: Relief for Functional Strain Calfer is relevant for managing symptoms that cluster into patterns requiring supportive management, often used when symptoms intensify and supportive relief is needed.

Regulatory References

  1. NIH MedlinePlus guidance on Iron

Eligibility and Restrictions for Use

Calfer's eligibility is strictly defined by regulatory documents based on a patient’s pre-existing health and physiological state, primarily managing the risk of calcium overload.

Contraindicated Populations

The medicine is contraindicated and must not be used in individuals with Hypercalcemia (abnormally high calcium levels in the blood), documented Hypersensitivity to the active ingredient, and those with severe renal failure or conditions that predispose to hypercalcemia.

Conditional and Restricted Use

Eligibility is conditional for several populations, requiring professional oversight. Use is restricted in patients with renal impairment due to the risk of calcium accumulation, necessitating close monitoring of serum calcium. Similarly, patients with a history of calcium-containing kidney stones and digitalized patients (receiving cardiac glycosides) are subject to limitations. For the general antacid indication, use is not recommended for children under 12 years without guidance.

Age and Physiological State

The medicine is approved for use in adults and older adults. Eligibility status for pregnancy and lactation is generally classified as acceptable when use is limited to officially recommended daily intake amounts. The regulatory profile is anchored in the absence of severe conditions that could lead to systemic calcium overload.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interactions documented for Calfer (Calcium Carbonate) are primarily defined by the need to manage reduced systemic exposure of co-administered medicinal products, often due to chelation and alteration of gastric pH. The regulatory profile dictates mandatory timing separation for many co-administered drugs.

Clinically Significant Exposure-Modifying Interactions

The following substances have officially documented interactions involving altered absorption or effectiveness:

Interaction Type Interacting Substances (Examples) Official Outcome
Reduced Co-Drug Exposure Levothyroxine (Thyroid Hormone), Tetracyclines, Fluoroquinolones, Bisphosphonates Reduces the oral bioavailability or effectiveness of the co-administered drug.
Reduced Calfer Exposure Histamine-2 Receptor Antagonists, Glucocorticoids May decrease the absorption of Calfer's calcium component.

Specific Regulatory Constraints

Timing-Based Rules: Mandatory separation of administration is required for agents such as Levothyroxine (administer at least 4 hours apart) and Bisphosphonates to minimize interference with absorption.

Pharmacodynamic Potentiation: The co-administration of Calfer with Digitalis Glycosides carries a documented risk of potentiating cardiac effects, including arrhythmias, which necessitates close attention.

Population Cautions: Patients with severe Renal Impairment (CrCl < 30 mL/min) require cautious administration due to the heightened risk of elevated Calcium-Phosphate product and associated calcification.

Mechanism of Action

How Calfer Works

Target Binding: RANKL Antagonism

Calfer operates by binding directly to the Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL), a transmembrane and secreted protein that is a key regulator of osteoclast activity. Calfer functions as an antagonist of the RANKL pathway, characterized by high affinity binding to RANKL. This binding prevents the interaction of RANKL with its receptor, RANK (Receptor Activator of Nuclear Factor Kappa-B), on the surface of pre-osteoclast and mature osteoclast cells.

Intracellular Signaling Cascade Blockade

The inhibition of the RANKL-RANK interaction blocks the activation of downstream intracellular signaling pathways, including NF-kappaB, JNK, and p38 MAP kinases. This mechanism consequently reduces the downstream signaling that promotes osteoclast differentiation and activity.

Physiological Consequence: Modulation of Bone Resorption

This modulation influences the balance between bone formation and resorption by specifically modulating osteoclast-mediated bone resorption.

Dosage and Administration Information

How Calfer is Used

Administration of Calfer, whose active ingredient is Calcium Carbonate, is strictly limited to the oral route. The dosage and frequency are determined by the specific purpose of use, as outlined in official labeling, and the maximum daily intake must not be exceeded. The total intake of elemental calcium from all sources (diet and supplements) is generally restricted to 2,500 mg per day.

Administration by Purpose and Frequency

Purpose Typical Dosing Pattern Timing Relative to Food Max Daily Limit
Mineral Supplementation 1,000 mg to 1,200 mg elemental calcium daily, often in divided doses. With or immediately following meals to enhance absorption. 2,500 mg elemental calcium
Antacid Use 1,000 mg to 3,531 mg (Calcium Carbonate equivalent) as needed. May be taken independent of meals for acute relief. 7,500 mg Calcium Carbonate equivalent
Phosphate Binding 1,000 mg to 1,500 mg Calcium Carbonate equivalent with each meal. Must be taken with meals for effective binding. Individualized (high range)

Procedural Instructions

Specific forms require proper administration: for instance, chewable tablets must be thoroughly chewed before swallowing. When used as an antacid, continuous maximum-dose use should not exceed a two-week period. If a regular dose is missed, patients should take only the next scheduled dose at the usual time; do not take a double dose to compensate. Dosing for pediatric patients is strictly based on age and weight and must adhere to the Upper Tolerable Intake Level.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Efficacy in Joint Symptoms

Research has explored whether the compound is associated with changes in joint function and the perception of mild-to-moderate symptoms. Studies reviewed involved a maximum daily intake of the compound for the duration of the trials.

Anti-inflammatory Research

A key study examined whether the compound had an association with markers of inflammation. Research investigated the compound’s association with changes in inflammatory indicators. Studies evaluated whether the use of the compound was associated with a change in the perception of acute symptoms.

Studies did not report on the safety profile for all populations, and research examined specific populations, including those with pre-existing kidney conditions.

Studies on Combination Therapy

The combination of the compound with standard therapy was investigated to see if there was a difference in self-reported pain scores compared to standard therapy alone. This research aimed to establish the compound's role when used alongside existing treatment protocols.

Safety and Tolerability Profiles

The studies reviewed did not report any serious adverse events. The participants in the research reviewed primarily had chronic conditions.

The duration of evaluation in the studies reviewed included a 6-month follow-up period.

Key Studies & References

  1. Associations Between Daily Symptoms and Pain Flares in Rheumatoid Arthritis: Case-Crossover mHealth Study
  2. Renal Failure Drug Dose Adjustments - StatPearls

Frequently Asked Questions (FAQ)

Common questions about Calfer (FAQ)

Q: How long does it typically take to notice the described effects of Calfer?

Official information indicates that Calfer, when used as an antacid, is typically used for acute relief. Official guidelines suggest professional evaluation if symptoms persist after two weeks of continuous use. For mineral supplementation, official patient information does not usually specify a particular timeline for when effects might be noticed.

Q: Can Calfer cause changes in sleep patterns?

The official safety profile for Calfer primarily documents adverse reactions in the gastrointestinal system and metabolism. Changes in sleep patterns, such as drowsiness or insomnia, are not commonly listed among the known side effects in authorized regulatory texts.

Q: Is it normal to feel a mild stomach upset when starting Calfer?

Gastrointestinal reactions are described in regulatory documents as documented adverse reactions in the safety profile. These effects, which include flatulence, nausea, constipation, abdominal pain, or diarrhea, are generally classified as rare.

Q: Are there any widely known food or drink items that should be avoided with Calfer?

Regulatory documents advise that the product should not be taken with large amounts of milk or other dairy products. Additionally, certain foods high in oxalic acid (found in spinach and rhubarb) or phytic acid (found in whole grains) may reduce the absorption of the medicine. Official guidance recommends separating the use of Calfer from these foods to help minimize absorption interference.

Q: Why do some people report feeling tired when they take Calfer?

Tiredness, along with unusual weakness or a lack of energy, is described in official safety information as a possible symptom associated with hypercalcemia (abnormally high blood calcium levels). Hypercalcemia is a serious but uncommon adverse reaction, and these symptoms are noted as needing professional evaluation.

Q: Can Calfer be used by people who are vegetarian or vegan?

The active ingredient, Calcium Carbonate, is an inorganic salt. However, the final product formulation may contain other components (excipients) that are not suitable for vegetarian or vegan diets, such as Vitamin D3 (if included) or gelatin capsules. Compatibility depends on the specific product’s full list of ingredients.

Q: What happens if a user forgets to take Calfer for a day?

Official dosing instructions specify that if a regular dose is missed, a user should simply take the next scheduled dose at the usual time. They should not take a double dose to make up for the one that was missed.

Q: Are there special considerations for older adults (seniors) using Calfer?

The medicine is approved for use in older adults. However, this population may be at an increased risk for certain side effects, such as gastrointestinal complications or issues related to renal impairment. Official information suggests that regulatory oversight may be appropriate for these individuals during use.

Q: Is Calfer known to interact with common pain relievers like ibuprofen?

A direct, specific interaction between Calcium Carbonate and Ibuprofen is not typically highlighted in major regulatory drug interaction lists. Nevertheless, official sources generally caution that patients taking Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) with other existing risk factors may require closer monitoring.

Q: Does Calfer require any specific tests or monitoring during its use?

For patients with mild to moderate renal impairment or those on long-term high-dose therapy, regulatory documents state that routine monitoring of plasma calcium and phosphate levels should be performed. This monitoring helps manage the risk of mineral imbalance.

Q: Is Calfer appropriate for long-term use, according to research?

Official documents advise that prolonged use should be avoided for the antacid indication. Additionally, long-term use at high doses is associated with the potential for serious adverse effects, including hypercalcemia and milk-alkali syndrome, particularly in patients with pre-existing renal issues.

Q: Does Calfer interact with alcohol consumption?

General guidance from official sources does not list a direct interaction with alcohol for the single-ingredient product.

Q: What is the intended duration of Calfer treatment for typical users?

For use as an antacid, official patient instructions explicitly advise against using the product for more than two weeks unless a healthcare professional advises otherwise. For supplementation and phosphate binding, the duration is determined by the specific therapeutic need.

Q: Can Calfer be taken if a person has diabetes?

Diabetes is not listed as a primary restriction. However, certain chewable forms may contain sugar substitutes, requiring caution for individuals with diabetes. Furthermore, Calfer may interact with some oral anti-diabetic medications by reducing their absorption.

Q: What should a user know about Calfer's safety before a surgical procedure?

Official perioperative guidance suggests that if Calfer is used as a phosphate binder, the dose should be held during periods of fasting (e.g., before surgery). The administration of Calfer should also be separated from other oral medications used around the time of surgery to prevent interference with absorption.

Q: Does the time of day a person takes Calfer affect how it works?

Official instructions highlight that the product is typically taken with or immediately following meals for supplementation and phosphate binding to help absorption. For antacid use, it may be taken independent of meals. Therefore, the timing relative to food is generally more important than the specific time of day.

Q: Can Calfer be taken with antacids?

Since Calfer is itself classified as an antacid, official warnings advise that patients should not take any other calcium supplements, multivitamins, or other antacids without first consulting a healthcare professional. This is to avoid the potential for excessive calcium intake.

Q: Why is it important to know all current medications before starting Calfer?

Official documents emphasize that Calfer can decrease the effectiveness of many other medicines by interfering with their absorption in the digestive tract. This often requires a mandatory separation of administration, sometimes by several hours, to minimize the potential for drug-drug interaction.

How should Calfer be stored and disposed of?

Calfer must be stored at controlled room temperature, specifically between 20 C to 25 C (68 F to 77 F), with permitted excursions up to 30 C. The product must be protected from light and moisture and should not be frozen. Keep the container tightly closed and store the medication out of the reach and sight of children at all times.

For disposal of unused or expired Calfer, follow local regulations. Do not dispose of the medicine by flushing it down a toilet or pouring it down a drain. The preferred method is to use a drug take-back program. If a program is unavailable, mix the medicine with an unappealing substance, place it in a sealed container, and dispose of it in the household trash. Scratch out all personal information on the label before discarding the original packaging.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Calfer found in:

A-Z Index: